National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Rhabdomyosarcoma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 11/25/2009
Table 4. COG-STS Rhabdomyosarcoma Risk Group Classification

Risk Group   Histology  Stage  Group 
Low risk Embryonal 1 I, II, III
Embryonal 2, 3 I, II
Intermediate risk Embryonal 2, 3 III
Alveolar 1, 2, 3 I, II, III
High risk Embryonal or Alveolar 4 IV


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov